Peer Review History
| Original SubmissionMarch 4, 2025 |
|---|
|
Dear Dr. Guntreddi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Khan Bahadar Khan, Ph.D Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No ********** Reviewer #1: The article introduces an Optimal Anisotropic Guided Filtering (OAGF) framework designed for retinal fundus image enhancement and segmentation. The study is well-targeted to address the challenges of non-invasive retinal vascular imaging, making it particularly relevant for applications in ophthalmology and early diagnosis of systemic diseases. The methodology is sound, integrating illumination correction, optimized top-hat transform, and homomorphic filtering, which contributes to robust image segmentation and enhancement. The paper is technically rigorous, with a comprehensive analysis of existing techniques and quantitative performance evaluation using DRIVE and STARE datasets. The results convincingly demonstrate superior performance compared to other segmentation methods. However, several aspects could be improved. The lack of a real clinical validation limits the study’s applicability to practical medical settings. Additionally, while the mathematical formulations are detailed, certain sections are too dense, making them less accessible to readers outside the field of image processing. Lastly, the computational complexity of the proposed approach is not sufficiently discussed, which may affect real-time applicability in clinical diagnostics. The authors should reflect the following arising issues to improve the quality of manuscript: 1. Expand Clinical Validation and Comparison with Manual Expert Segmentation The study primarily evaluates OAGF against existing computational methods but lacks validation against manually segmented clinical datasets or expert ophthalmologist assessments. Including this comparison would improve the credibility of the proposed method and its suitability for real-world medical applications. 2. Clarify Computational Complexity and Feasibility for Real-Time Applications The proposed framework involves multiple processing stages, including top-hat transform, guided filtering, and homomorphic filtering, which may increase computational cost. A discussion on runtime performance, memory requirements, and potential hardware acceleration (e.g., GPU optimization) should be added to assess its feasibility in clinical practice. 3. Improve Readability of Mathematical Derivations and Methodology While the article provides a mathematically rigorous formulation of OAGF, some key equations and algorithmic steps are dense and challenging to interpret. Including more intuitive explanations, flowcharts, and illustrative diagrams would make the methodology more accessible to interdisciplinary researchers. 4. Address Potential Limitations and Biases in the Dataset The study relies on DRIVE and STARE datasets, which are standard but relatively small and homogeneous. Discussing potential biases, dataset variability, and the effect of image quality variations (e.g., different fundus camera settings, patient demographics) would strengthen the paper’s generalizability. Reviewer #2: The paper presents a promising approach to retinal image enhancement and segmentation using OAGF. However, improvements in readability, justification, experimental validation, and comparative analysis with deep learning methods are necessary to strengthen the contribution. By addressing these issues, the manuscript can significantly improve in clarity, rigor, and impact. The manuscript contains several long and complex sentences that make comprehension difficult. Simplifying technical explanations and improving readability would enhance accessibility. Break down dense paragraphs into shorter, more digestible sections. In abstract, the manuscript does not clearly specify which publicly available databases were used. Providing names (e.g., DRIVE, STARE, or CHASE-DB1) will help contextualize the results. Specify the databases used and include detailed performance metric comparisons. Incorporate a concise summary of the key results or findings in the abstract to provide readers with an overview of the study's outcomes. This approach offers a more comprehensive understanding of the research and encourages readers to explore the detailed results within the full paper. The introduction is dense and could be structured more clearly to gradually introduce the problem and background before diving into specific enhancement and segmentation methods. Clearly define the problem statement before diving into technical discussions. In section (Introduction), it’s better to clarify the whole structure of the paper, which can be easier for the reader to understand what scenarios have been investigated or examined and what’s the main contribution this paper makes. For example, this paper is organized as follows: section 2 presents what and section 3 presents what… It’s suggested to give a brief overview of the entire paper in the introduction. It is better to cite any relevant survey article in the introduction section to give an overview of the topic. e.g. Khan et al. "A review of retinal blood vessels extraction techniques: challenges, taxonomy, and future trends." Pattern Analysis and Applications 22 (2019): 767-802. The novelty of OAGF compared to existing anisotropic guided filtering methods needs better articulation. The paper should emphasize why OAGF is superior in more detail beyond computational efficiency and adaptability. Provide a more detailed discussion on how OAGF improves upon existing methods mathematically and practically. The equations provided (e.g., Equations 1-3) lack sufficient explanation regarding their derivation and how they improve upon existing techniques. Introduce more intuitive explanations for key equations. The explanation of the weight function in equation (6) could be expanded with more intuitive descriptions of its impact on filtering. The study lacks an explicit discussion on the computational complexity of the OAGF filter compared to other methods. Hybrid approaches integrating OAGF with CNN-based feature extraction should be investigated. While the DRIVE and STARE datasets are commonly used in retinal imaging research, the robustness of the method should be tested on additional datasets like CHASE_DB1 or HRF for further validation. It would be beneficial to conduct an ablation study to assess the individual contributions of OAGF, Top-Hat Transform, and Homomorphic Filtering. Demonstrating performance variations when each component is removed or replaced would provide deeper insight into the necessity of each step. Highlighting specific cases where the proposed method performs significantly better (or worse) than contemporary methods can provide further insights. The result section overwhelmingly highlights the superiority of OAGF without adequately discussing its limitations. For example, it is noted that Segmentation-3 and Segmentation-4 struggle with finer vessel details, but no insight is provided into why this occurs or how it might be addressed. Introduce a more balanced critique by acknowledging the challenges of OAGF, such as potential issues in handling extreme low-contrast images or cases with significant noise. While Table 2 presents performance metrics, no statistical significance tests (e.g., t-tests, ANOVA) are conducted to validate whether OAGF's improvements are statistically meaningful. Include statistical tests to confirm whether the observed performance gains are significant or within the margin of error. The discussion asserts that OAGF “outperforms all existing methods,” but does not explain the algorithmic reasons for its success in depth. While it is clear that OAGF achieves higher accuracy, a more technical explanation of why it excels over deep learning-based methods (e.g., IUNet) is missing. Elaborate on the key architectural or mathematical advantages of OAGF that lead to its improved performance. The enhancement analysis mentions that OAGF “strikes the perfect balance” between detail preservation and contrast improvement. However, there is minimal discussion on how it achieves this balance compared to methods like NSCT or CLA. Provide a deeper technical explanation of how OAGF optimizes contrast and detail enhancement while minimizing artifacts. Figure 3 and Figure 5 provide valuable insights, but their descriptions lack detailed interpretations. For instance, it is mentioned that morphological filtering results in a “sparse, fragmented extraction,” but a more detailed explanation of how this affects clinical usability would strengthen the analysis. Improve the figure descriptions by explicitly linking the observed segmentation/enhancement quality to medical relevance and practical applicability. Include some relevant papers in the comparison of results. For example https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158996 ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Vijay Govindarajan ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Guntreddi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Khan Bahadar Khan, Ph.D Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** Reviewer #1: I have rerevised the modified manuscript. In my opinion, the authors have improved the modified manuscript in a sufficient manner to study meets standards and quality of scholarly papers. I am the opinion, that the paper has scientific rigor and well completes the state-of-the-art in the area retinal image segmentation. Reviewer #2: The authors have addressed the majority of the previous' comments; however, several points still require more precise and comprehensive clarification. The Introduction section introduces the OAGF framework and outlines the rest of the paper’s structure, which aligns with reviewer suggestions. However, the following shortcomings are still present: Long, unbroken paragraphs make comprehension difficult. Break large paragraphs into shorter ones for better readability. The novelty of OAGF over other guided filtering techniques is not clearly highlighted (e.g., how does it differ from anisotropic diffusion or other edge-preserving methods?). Add a subsection or paragraph clearly stating how OAGF differs from existing filters, both mathematically and practically. Consider summarizing traditional vs. deep learning segmentation shortcomings in a table or bullet list for clarity. The OAGF is introduced as an “optimal” enhancement to AGF, but the specific mathematical or architectural innovations (e.g., how coefficients are “optimized” or how it differs in design principles from AGF) are not clearly articulated in contrast with prior work. Add a bullet-point or tabular comparison of mathematical innovations. Explicitly state what is new about your “optimal” weighting compared to AGF. Table 1, while useful, is qualitative and lacks metrics or empirical backing. What happens in very low-contrast regions or high-noise inputs? Is the method robust to anatomical variability across datasets? Briefly explain how homomorphic filtering enhances vessel contrast by targeting frequency differences typical of vascular edges versus background, or include a visual before/after comparison. Include discussion on where the method might struggle (e.g., extremely low-contrast images, overlapping vessels, bright lesions mimicking vessel intensity). While numerous metrics (BRISQUE, NIQE, PIQE, IMMSE, PSNR, SSIM) are reported across multiple test samples, no statistical significance tests (e.g., t-test, Wilcoxon signed-rank test) are applied to confirm that the differences between OAGF and baseline methods are not due to random variation. Apply paired t-tests, Wilcoxon signed-rank, or ANOVA to key metrics (e.g., DC, IoU, F1) across test images to establish statistical superiority. Figures 4(i) and 4(ii) present only bar values without error margins. Add standard deviation bars or box plots to convey performance variability across test cases. Fig. 5 also lack of error maps. Although BRISQUE and NIQE scores are mentioned, the paper doesn’t specify what ranges indicate well vs. poor quality. Include interpretive guidance—e.g., "BRISQUE < 30 indicates good perceived quality. While the TS-4 and TS-6 limitations are noted, no visual examples or deeper failure mode analysis is shown (e.g., where thin vessels are lost, or false positives occur). Show side-by-side visual comparisons of failure cases and briefly hypothesize the cause (e.g., low contrast, noise). While several filter parameters (e.g., t,dx,ϵ) influence OAGF performance, there is no analysis of how sensitive the performance is to these hyperparameters. Include a brief sensitivity analysis or at least a statement acknowledging the need for parameter tuning in deployment scenarios. The large tables (Table 4) are rich in data but lack mean ± standard deviation summaries or any interpretation of variance. Summarize each metric across samples with mean ± SD, and highlight statistically significant improvements in bold or with asterisks. Reviewer #3: Authors have made all possible changes and reply all comments and no more further queries are required ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Vijay Govindarajan Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Dear Dr. Guntreddi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Khan Bahadar Khan, Ph.D Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: I am the opinion that the revised manuscript has undergone substantial revisions. Based on the author’s reactions and the highlighted modifications it seems to be the revised manuscript has acceptable quality and scientific rigor. Therefore, I am the opinion that can be accepted in the present form. Reviewer #2: While the section “2.1.2 Structural Awareness…” elaborates on regional adaptivity and structural preservation, a direct, bullet-point/tabular comparison highlighting “what’s new in OAGF vs. AGF” in practical deployment terms would enhance clarity further. Although it is mentioned in the pipeline (Lines 43–44), the specific rationale for how homomorphic filtering enhances contrast via frequency separation is not clearly explained. A short paragraph or figure showing its effect on vessel contrast is still missing. The limitations of prior filters are noted, but no discussion is present yet on where OAGF might fail (e.g., overlapping vessels, low-contrast lesions). No visual failure cases are included. Equations and detailed formulas are now included (e.g., Eq. 24–29). However, no interpretive scale (e.g., “BRISQUE < 30 = high quality”) or guidance for what counts as a good score is provided. While parameters like t, dx, and ϵ are referenced in Eq. (9), there is still no discussion of sensitivity or robustness to these parameters. While the section 4.3.2 compares OAGF against a set of conventional image processing methods (CLA, DWT, NSCT, etc.), it does not include or reference recent unsupervised or hybrid segmentation techniques, which are highly relevant for enhancing retinal vessel visibility. https://doi.org/10.1155/2020/8365783 Add a runtime analysis or mention the average processing time per image compared to other methods. Consider citing and briefly discussing the following paper in Section 4.3.2 (suggest after line 710 or in limitations at line 775): Khan, K.B., Khaliq, A.A. and Shahid, M., 2017. “A Novel Fast GLM Approach for Retinal Vascular Segmentation and Denoising,” Journal of Information Science and Engineering, 33(6), 1611–1627. Include standard statistical tests (e.g., paired t-tests or Wilcoxon signed-rank) across metric distributions to verify that observed improvements by OAGF are statistically significant and not due to sample variance. Add one paragraph discussing how improved microvascular clarity (via OAGF) supports diagnosis of diabetic retinopathy, glaucoma, or hypertensive retinopathy. The results are derived solely from DRIVE and STARE datasets. While they are standard, these datasets lack diversity in pathological variations and image acquisition conditions. Mention this limitation and recommend validation on CHASE_DB1, HRF, or ARIA, which include pathological cases and varied resolutions. Also, consider stating the adaptability of OAGF across different imaging conditions. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Vijay Govindarajan ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 3 |
|
<p>Optimal Anisotropic Guided Filtering in Retinal Fundus Imaging: A Dual Approach to Enhancement and Segmentation PONE-D-25-11375R3 Dear Dr. Guntreddi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Khan Bahadar Khan, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-11375R3 PLOS ONE Dear Dr. Guntreddi, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Khan Bahadar Khan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .